Market and Volatility Commentary December Post-Mortem, Signals from Fund Flows, Role of Systematic Flows and Reversion December Post-Mortem Over the past month, the confidence of equity investors virtually collapsed. The month of December proved us wrong in the view that the market would rise into year-end and in 2018 overall. Our call for a year-end recovery was based on near-…
Post Mortem Commentary From J.P. Morgan Chase & Fund Flow Trend Analysis
A financial market resource for the every-day investor and trader.
-
Will April & Earnings Season Change The Tide For The S&P 500?
Seth Golden, , Research Reports, 0
Investors are hopeful that April proves a better month for equities than did March and after closing out a...
-
-
From Crisis to Resolve in 2019? Markets Favor The Latter
Seth Golden, , Research Reports, 0
Languishing over the 2018 market won’t do investors any good, but it is important to reflect on what made...
-
A Positive October, To-Date And a 6-Month Win Streak To Be?
Seth Golden, , Research Reports, 0
Good weekend Finom Group investors and traders! This is our “off-reporting” weekend. Please take some time to read our...
-
Managing VIX-Leveraged ETPs Through Earnings Season, Political Strife And A Frothy Market
Seth Golden, , Research Reports, 0
In 2015, I penned my first article on the subject matter surrounding VIX-leveraged ETF/ETNs. Back then, as if it...
-
J.P. Morgan Team Offers Completed 2021 Analysis
Seth Golden, , Research Reports, 0
Equities are facing one of the best backdrops for sustained gains next year. After a prolonged period of elevated...
-
Leuthold Group: Market Signals Increase Exposure
Seth Golden, , Research Reports, 0
Doug Ramsey Chief Investment Officer & Portfolio Manager: Doug is the Chief Investment Officer of The Leuthold Group, LLC, and...
-
Morgan Stanley: Reaching Herd Immunity
Seth Golden, , Research Reports, 0
When can the US achieve broad vaccination of its population: Using the current rate of daily vaccinations (red line,...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00